EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy

Ahmed M Abu El-Asrar iD, Mohd I Nawaz iD, Ajmal Ahmad, Luna Dillemans, Mairaj Siddiquei iD, Eef Allegaert, Priscilla W Gikandi, Gert De Hertogh, Ghislain Opdenakker iD, Sofie Struyf iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ahmed M Abu El-Asrar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia for funding this research (IFKSURC-1-2101) (AMA)., Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia, Rega Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We aimed to investigate the role of the CD40-CD40 ligand (CD40L) pathway in inflammation-mediated angiogenesis in proliferative diabetic retinopathy (PDR). We analyzed vitreous fluids and epiretinal fibrovascular membranes from PDR and nondiabetic patients, cultures of human retinal microvascular endothelial cells (HRMECs) and Müller glial cells and rat retinas with ELISA, immunohistochemistry, flow cytometry and Western blot analysis. Functional tests included measurement of blood–retinal barrier breakdown, in vitro angiogenesis and assessment of monocyte-HRMEC adherence. CD40L and CD40 levels were significantly increased in PDR vitreous samples. We demonstrated CD40L and CD40 expression in vascular endothelial cells, leukocytes and myofibroblasts in epiretinal membranes. Intravitreal administration of soluble (s)CD40L in normal rats significantly increased retinal vascular permeability and induced significant upregulation of phospho-ERK1/2, VEGF, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). sCD40L induced upregulation of VEGF, MMP-9, MCP-1 and HMGB1 in cultured Müller cells and phospo-ERK1/2, p65 subunit of NF-ĸB, VCAM-1 and VEGF in cultured HRMECS. TNF-α induced significant upregulation of CD40 in HRMECs and Müller cells and VEGF induced significant upregulation of CD40 in HRMECs. sCD40L induced proliferation and migration of HRMECs. We provide experimental evidence supporting the involvement of the CD40L-CD40 pathway and how it regulates inflammatory angiogenesis in PDR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyDiabetes MellitusHumansRatsAnimalsCD40 LigandEndothelial CellsVascular Cell Adhesion Molecule-1Vascular Endothelial Growth Factor ARats, Sprague-DawleyInflammation

Stichwörter der Autor:innen

CD40 ligandangiogenesisendothelial cellsinflammationproliferative diabetic retinopathy

Substanzen

CD40 LigandVascular Cell Adhesion Molecule-1Vascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia.
  • Dr. Nasser Al-Rashid Research Chair in Ophthalmology, College of Medicine, King Saud University, Riyadh 11411, Saudi Arabia.
  • Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, Rega Institute, University of Leuven, 3000 Leuven, Belgium.
  • Laboratory of Histochemistry and Cytochemistry, University of Leuven, 3000 Leuven, Belgium.
  • University Hospitals UZ Gasthuisberg, 3000 Leuven, Belgium.
  • Laboratory of Immunobiology, Department of Microbiology, Immunology and Transplantation, Rega Institute, University of Leuven, 3000 Leuven, Belgium.

ORCID-Profile: Ahmed M Abu El-Asrar, Mohd I Nawaz, Mairaj Siddiquei, Ghislain Opdenakker, Sofie Struyf

Förderung

  • This work was supported by the Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia for funding this research (IFKSURC-1-2101) (AMA).
  • Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia
  • Rega Institute
  • Fundamental Research of FWO Flanders

Zitieren

APA

Abu El-Asrar, A. M., Nawaz, M. I., Ahmad, A., Dillemans, L., Siddiquei, M., Allegaert, E., Gikandi, P. W., De Hertogh, G., Opdenakker, G., & Struyf, S. (2023). CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115582

Vancouver

Abu El-Asrar AM, Nawaz MI, Ahmad A, Dillemans L, Siddiquei M, Allegaert E, et al. CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115582

BibTeX
@article{AbuElAsrar2023,
  author = {Abu El-Asrar, Ahmed M and Nawaz, Mohd I and Ahmad, Ajmal and Dillemans, Luna and Siddiquei, Mairaj and Allegaert, Eef and Gikandi, Priscilla W and De Hertogh, Gert and Opdenakker, Ghislain and Struyf, Sofie},
  title = {CD40 Ligand–CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115582}
}
Kostenlos starten →